An industrially scalable two-step process for preparing a β-L-2′-deoxy-nucleoside that results in a predominance of the β- over the γ-anomeric form of the compound is described. An optional third step may be used to prepare 3′-prodrugs of desirable β-L-2′-deoxy-nucleosides for the delivery of these pharmaceuticals effective for treating viral diseases. The synthetic process is applicable in particular to the formation of β-L-2′-deoxy-cytidine, a pharmaceutically acceptable salt or prodrug thereof. The process can provide a relatively uncontaminated product that may require no further isolation or purification, thereby making the synthesis easily scalable for industrial manufacture.
本文介绍了一种工业可扩展的两步法制备β-
L-2'-去氧核苷的方法,该方法使化合物的β-异构体形式优于γ-异构体形式。第三步是可选的,可用于制备所需的β-
L-2'-去氧核苷3'-前药,以便有效治疗病毒性疾病。该合成过程特别适用于形成β-
L-2'-去氧
胞苷,其药用盐或前药。该过程可以提供相对不受污染的产品,可能不需要进一步的分离或纯化,从而使合成易于工业生产规模化。